Skip to main content

Table 3 Glycaemic variability

From: Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan: prospective observational study

 

Insulatard (n = 15)

Levemir (n = 16)

Glargine (n = 15)

p-value

Glycaemic variability; (%)

37.20 (9.8)

34.45 (14.8)

36.80 (18.2)

0.988

Glycaemic variability; n (%)

    

 Good variability

 Poor variability

6 (27.3)

9 (37.5)

9 (40.9)

7 (29.2)

7 (31.8)

8 (33.3)

0.666

  1. Data are presented as median (IQR) for continuous variables and number (percentage) for categorical variables. p-value are results of the non-parametric Kruskal Wallis test for both continuous and categorical variables between three groups of insulin. CV ≥ 36% indicates high glycaemic variability
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us